Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation

Olivier Corbeil, Anne Marie Essiambre, Laurent Béchard, Audrey Anne Roy, Maxime Huot-Lavoie, Sébastien Brodeur, Ranjith Chandrasena, Chantale Thériault, Candice Crocker, Jean Pierre Melun, Phil Tibbo, Marie France Demers, Marc André Roy

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)
Original languageEnglish
JournalTherapeutic Advances in Psychopharmacology
Volume12
DOIs
Publication statusPublished - 2022
Externally publishedYes

ASJC Scopus Subject Areas

  • Psychology (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Keywords

  • antipsychotic
  • long-acting injectable
  • naturalistic setting
  • paliperidone palmitate 1-monthly
  • paliperidone palmitate 3-monthly
  • psychotic disorder
  • relapse
  • schizophrenia

Fingerprint

Dive into the research topics of 'Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation'. Together they form a unique fingerprint.

Cite this